Ohio Administrative Code › Title 5122 - Department of Mental Health and Addiction Services › Chapter 5122-40 - Methadone Treatment License › Section 5122-40-01 - Definitions and applicability

Current through all regulations passed and filed through July 1, 2024
(A) In addition to the definitions listed in
			 rule
			 5122-24-01
			 of the Administrative Code, the following definitions apply to Chapter 5122-40
			 of the Administrative Code.
(1)
			 "Administration" means the direct application of medication assisted treatment
			 to a client.
(2) "Department" mean
			 the Ohio department of mental health and addiction services.
(3) "Detoxification" means the administering
			 of any medication in decreasing doses to an individual to alleviate adverse
			 physiological or psychological effects of withdrawal from the continuous use of
			 a narcotic drug and as a method of bringing the individual to an opiate
			 drug-free state.
(4) "Dispense"
			 means the final association of any medication for take home doses with a
			 particular patient pursuant to the prescription, drug order or other lawful
			 order of the prescriber and the professional judgment of and responsibility
			 for: interpreting, preparing, compounding, labeling and packaging of any
			 medication used for medication assisted treatment.
(5) "Interim maintenance" means maintenance
			 provided in conjunction with appropriate medical services while a patient is
			 awaiting transfer to a program that provides comprehensive
			 maintenance.
(6) "Long-term
			 detoxification" means the administering of medication assisted treatment for
			 detoxification of a patient for a period of more than thirty days but not in
			 excess of one hundred eighty days.
(7) "Medication-assisted treatment" has the
			 same meaning as in section
			 340.01
			 of the Revised Code."
(8) "Medical
			 director" is a physician, licensed to practice medicine in Ohio by the state of
			 Ohio medical board, who assumes the responsibility for the delivery of all
			 medical services performed by the program, either by performing them directly
			 or by delegating specific responsibility to authorized program physicians and
			 qualified healthcare professionals functioning under the medical director's
			 direct supervision.
(9) "Medication
			 unit" means any center for substance abuse treatment (CSAT) approved facility
			 established as part of, but geographically separate from, an opioid treatment
			 program from which mediation assisted treatment is administered or
			 dispensed.
(10) "Medication
			 maintenance" means the administering or dispensing of medication assisted
			 treatment at stable dosage levels for a period in excess of twenty-one days in
			 the treatment of a patient for opioid addiction.
(11)
									"Mobile unit"
			 means a vehicle that is associated with an opioid treatment program. Mobile
			 units can dispense narcotic drugs in schedules II-V at remote locations for the
			 purpose of maintenance or detoxification.
(12) "Opioid treatment
			 program" or "program" means a community addiction services provider that
			 engages in supervised assessment and treatment, 
									dispensing any
			 form of medication assisted treatment for individuals who have opioid use
			 disorders. Services include medically supervised withdrawal and/ or maintenance
			 treatment, along with various levels of medical, psychiatric, psychosocial, and
			 other types of supportive care.
(13) "Partial opioid
			 agonist" means buprenorphine products or combination products approved by the
			 federal food and drug administration for maintenance or detoxification of
			 opioid dependence, or any other partial agonists federally approved, controlled
			 substances used for the purpose of opioid replacement treatment. These
			 medications are used as an alternative to opioid agonists in the treatment of
			 opioid addiction. At certain dosages, a partial agonist can both activate and
			 block the effects of opioid medications or receptors, thereby assisting in
			 control of opioid addiction. Partial agonists bind to the receptors and
			 activate them, but not to the same degree as full agonists.
(14)
			 "Permanent patient transfer" means the transfer of a patient from one opioid
			 treatment program to another opioid treatment program.
(15)
			 "Physician extender" means a qualified medical staff person other than a
			 physician, functioning within his or her scope of practice to provide medical
			 services to patients admitted to opioid treatment programs.
(16)
			 "Principal" means a person who has controlling authority or is in a leading
			 position, e.g., executive director, chief financial officer, chief clinical
			 officer, chief operating officer.
(17) "Program
			 administrator" is a person who is responsible for the day-to-day operation of
			 the opioid treatment program in a manner consistent with the laws and
			 regulations of the United States department of health and human services,
			 United States drug enforcement administration, and the laws and rules of the
			 state of Ohio.
(18) "Program sponsor"
			 is a person or representative of the program, who is responsible for the
			 operation of the opioid treatment program and who assumes responsibility for
			 all of its employees, including any practitioners, agents or other persons
			 providing medical, rehabilitative or counseling services at the
			 program.
(19) "SAMHSA" means
			 the federal substance abuse and mental health services
			 administration.
(20) "Short-term
			 detoxification" means the administering of a medication assisted treatment for
			 detoxification of a patient for a period not to exceed thirty days.
(21)
			 "State authority" or "state opioid treatment authority" (SOTA) means the agency
			 or individual designated by the Ohio department of mental health and addiction
			 services to exercise the responsibility and authority of the state for
			 governing the treatment of opiate addiction by an opioid treatment program. The
			 state authority shall act as the state's coordinator for the development and
			 monitoring of opioid treatment programs and shall serve as a liaison with the
			 appropriate federal, state and local agencies.
(22) "State oversight
			 agency" means the agency or office of state government identified by the
			 governor to provide regulatory oversight of opioid treatment programs on behalf
			 of the state of Ohio. The designated state oversight agency is responsible for
			 licensing, monitoring and investigating complaints or grievances regarding
			 opioid treatment programs. The Ohio department of mental health and addiction
			 services is the agency designated by the governor to provide regulatory
			 oversight on behalf of the state of Ohio.
(23)
									"Telemedicine"
			 or "telemedical" as used in this chapter have the same meaning as telehealth as
			 defined in rule
			 5122-29-31 of the
			 Administrative Code.